SCHEMBL6350199

SCHEMBL6350199

CCc1cnc(CC)c(N[C@H](C)CC)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HSP90AA1 P07900 1/20 0.37
CYP3A4 P08684 1/20 0.37
THRB P10828 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
CASP1 P29466 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HIF1A Q16665 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.36
CRHR1 P34998 6/20 0.36
LATS1 O95835 3/20 0.36
LATS2 Q9NRM7 3/20 0.36
HCAR3 P49019 1/20 0.36
LRRK2 Q5S007 1/20 0.35
MEN1 O00255 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6345411 1.00 TP53 (0.37) TP53ALDH1A1HSP90AA1CYP3A4THRB
SCHEMBL6167497 0.87 TLR8 (0.40) CRHR1HCAR3
SCHEMBL6166421 0.85 CRHR1 (0.49) CRHR1
SCHEMBL6168054 0.80 CRHR1 (0.42) TP53ALDH1A1SMN1; SMN2CRHR1LATS1
SCHEMBL6167603 0.80 CRHR1 (0.42) TP53ALDH1A1SMN1; SMN2CRHR1LATS1
SCHEMBL6166430 0.79 CRHR1 (0.38) CRHR1
SCHEMBL6167318 0.78 CYP1A2 (0.33) ALDH1A1SMN1; SMN2HIF1ATDP1L3MBTL1
SCHEMBL6345782 0.77 CRHR1 (0.49) ALDH1A1SMN1; SMN2HSD17B10CRHR1LATS1
SCHEMBL6344899 0.77 CRHR1 (0.49) ALDH1A1SMN1; SMN2HSD17B10CRHR1LATS1
SCHEMBL6168593 0.76 CRHR1 (0.46) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6964965-B2 Substituted pyrazine derivatives PHARMACIA & UPJOHN (US) 2005-11-15 US disclosed
US-20040053941-A1 Substituted pyrazine derivatives PHARMACIA & UPJOHN COMPANY 2004-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053941-A1 Substituted pyrazine derivatives CRHR1, CRHR2, CRH TP53 4754/4885ALDH1A1 749/4885HSP90AA1 2937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.